Condition
Hemorrhagic Disorders clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Hemorrhagic Disorders clinical trials that are recruiting, at sites in 3 countries (most in France (2), Netherlands (1), United States (1)). By phase: Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Hemorrhagic Disorders clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Unexplained bleeding disorders in the Netherlands | — | Nijmegen, Gelderland and 7 other locations | Recruiting | Mar 6, 2026 |
| How well different thromboplastin reagents work for prothrombin time in certain liver and factor deficiencies | Phase 4 | Strasbourg | Recruiting | May 15, 2025 |
| Comparing thromboplastin reagents for prothrombin time and clotting factor tests | — | Strasbourg | Recruiting | Nov 26, 2024 |
| Evaluating a new CAR-T cell therapy for relapsed/refractory multiple myeloma | Phase 1 | Atlanta, Georgia | Recruiting | Feb 21, 2024 |
All recruiting trials (4)
-
Unexplained bleeding disorders in the Netherlands
This project will try to find blood-based and genetic reasons for unexplained bleeding in people referred to hemostasis centers in the Netherlands.
-
How well different thromboplastin reagents work for prothrombin time in certain liver and factor deficiencies
This study tests several thromboplastin reagents to see how they affect prothrombin time in patients with isolated extrinsic pathway deficiencies or liver-related coagulopathy.
-
Comparing thromboplastin reagents for prothrombin time and clotting factor tests
This project tests whether different thromboplastin reagents change prothrombin time and factor II, V, VII, and X results in people with isolated extrinsic pathway deficiencies or liver-related coagulopathy.
-
Evaluating a new CAR-T cell therapy for relapsed/refractory multiple myeloma
This study is testing a new CAR-T cell therapy called OriCAR-017 to see if it can help people with relapsed or refractory multiple myeloma feel better and improve their treatment outcomes.
Related topics
Quick answers
How many Hemorrhagic Disorders clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (2 trials), Netherlands (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.